Christopher Highfill, MD
Foot and Ankle Surgery · Manassas, VANPI 1790778389
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.8%), education and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 69.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,706 and has fallen 68.0% since, to $866 in 2025.
Across 83 payments — averaging $130.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- Fortis Surgical, LLC$2K
- Johnson & Johnson$1K
- Medical Device Business Services, Inc.$46
- Stryker$41
- Integra Lifesciences Corporation$40
- plus $36 from 2 others
What the payments were for
- Travel & lodging$5,18148%
- Food & beverage$1,88717%
- Education$3,77435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 57 | $7,523 |
| Fortis Surgical, LLC | 12 | $2,133 |
| Johnson & Johnson | 7 | $1,023 |
| Medical Device Business Services, Inc. | 2 | $46 |
| Stryker | 2 | $41 |
| Integra Lifesciences Corporation | 1 | $40 |
| Acumed LLC | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,842 in reported general payments places this provider in the 75th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 34 | $252 |
| Cefadroxil | 23 | $215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 30 | $213 |
| Methylprednisolone | 15 | $69 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Manassas
- Stephanie AvnerManassas$18K
- Vineela AyyagariManassas$13K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Steven NeufeldFalls Church$857K
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.